Immunic (IMUX) announced the appointment of Jon Congleton to its board of directors, effective March 27. Congleton currently serves as CEO and member of the board of directors of Mineralys Therapeutics (MLYS)
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMUX: